妊娠期高血壓治療中拉貝洛爾與硫酸鎂聯(lián)合治療方案作用分析與探討

打開文本圖片集

【摘要】目的：分析對妊娠期高血壓患者合用拉貝洛爾和硫酸鎂的治療價(jià)值。方法：隨機(jī)抽取本院2022年1月—2024年1月76例妊娠期高血壓患者作為研究樣本，借助隨機(jī)數(shù)字表法分為兩組，每組38例，對照組采用硫酸鎂進(jìn)行治療，觀察組采用拉貝洛爾+硫酸鎂治療。比較兩組治療效果。結(jié)果：治療后，與對照組相比，觀察組SBP、DBP及24h尿蛋白定量水平均更低，P

【關(guān)鍵詞】妊娠期高血壓；拉貝洛爾；硫酸鎂；妊娠結(jié)局

Analysis and exploration of the effect of combination therapy of labetalol and magnesium sulfate in the treatment of gestational hypertension

ZHANG Juan， HE Qiaoyun

Wudu District First People’s Hospital， Longnan， Gansu 746000， China

【Abstract】Objective：To analyze the therapeutic value of combining labetalol and magnesium sulfate in patients with gestational hypertension.Methods：76 patients with gestational hypertension in our hospital from January 2022 to January 2024 were randomly selected as the study sample.They were divided into two groups using a random number table method，with 38 cases in each group.The control group was treated with magnesium sulfate，while the observation group was treated with labetalol + magnesium sulfate.The therapeutic effects of the two groups were compared.Results：After treatment，compared with the control group，the levels of SBP，DBP and 24-hour urinary protein quantification in the observation group were all lower （P

【Key？Words】Gestational hypertension； Labetalol； Magnesium sulphate； Pregnancy outcome

近年來，妊娠期高血壓在產(chǎn)科臨床中比較常見，是分娩產(chǎn)婦的高發(fā)并發(fā)癥，該并發(fā)癥的出現(xiàn)對孕產(chǎn)婦的健康安全狀況構(gòu)成較大影響和威脅，若未能有效治療和干預(yù)甚至可導(dǎo)致產(chǎn)婦死亡、圍產(chǎn)兒死亡，此并發(fā)癥是引起不良母嬰結(jié)局的一個(gè)常見原因[1]。（剩余4349字）